Vers la page d'accueil
4.6/5
TrustPilot

Les Meilleurs doctors pour le traitement de polykystose rénale en Chine - TOP-1 des médecins

Comparez les meilleurs médecins Polykystose rénale et les prix en Chine. Trouvez votre meilleure correspondance ici.

Obtenez des devis de 3 meilleurs spécialistes en Chine

Nous sélectionnons à la main les meilleurs médecins selon vos besoins et votre budget.

Meilleurs médecins

1

Chine

Avis

14000+

De vrais patients

Obtenez gratuitement des plans de traitement personnalisés et choisissez la meilleure option. Sans engagement · Aucun paiement pour nos services

Wang He Tian

  • Nouveau
  • 42 années d'expérience
  • Lieu : Chine, Pékin
  • Wang He Tian est un expert de premier plan en médecine traditionnelle chinoise, spécialisé dans le traitement des maladies rénales à l'hôpital international de Yanda.

    • Chef du département de médecine traditionnelle chinoise
    • Lauréat du prix de la Commission des sciences et de la technologie de Pékin pour le progrès scientifique et technologique
    • Auteur de plus de 10 ouvrages cliniques sur la médecine traditionnelle chinoise
    • Directeur adjoint du comité de travail sur l'héritage et le développement de la médecine chinoise
  • Lire la suite
Visite du médecin
Prix sur demande

Choisir une clinique à l'étranger peut être stressant. Chez Bookimed, avec plus de 800 000 patients aidés, nous comprenons vos préoccupations. Nous savons comment trouver des médecins de confiance, les meilleures options qualité-prix, et des solutions pour les cas les plus complexes. Nous sommes là pour vous guider à chaque étape.

Yan Matsiivskiy

Responsable de l'équipe de coordination médicale

4300++ parcours patients accompagnés

3 années chez Bookimed

22 patients du China ont trouvé leur médecin grâce à nous ce mois-ci

Comment obtenir la meilleure correspondance avec un médecin

1

Quiz de 2 minutes

Indiquez-nous votre objectif, budget, délai

2

Appariement humain + IA

Notre algorithme trouve des correspondances, le coordinateur vérifie l'adéquation

3

Vos options prêtes

Comparez les prix, forfaits, dates. Discutez avec votre coordinateur

Trop de choix ?

Votre personnel Le coordinateur Bookimed vous aide à trouver le chirurgien idéal adapté à vos besoins

  • Vous accompagne à chaque étape, 24h/24 et 7j/7
  • Vous aide à trouver le bon médecin et gère toute la communication avec les cliniques
  • Coordonne vos déplacements, hébergement et transferts

Accompagnement de votre traitement

Coordinateurs médicaux personnels formés

Peguy Beaugris
Tetyana Hyrych
Zekra Eldeeb
Victoria Olayinka
Iryna Sydorchuk
Tetiana Ihnatiuk

Choisir le bon médecin et la bonne clinique : conseils d'initiés

Lors du choix d’un médecin ou d’une clinique, gardez ces points essentiels à l’esprit :
Vérifiez les qualifications
Vérifiez les certifications d’organismes tels que l’ISAPS, la JCI, etc.
Examinez les taux de réussite
Choisissez des médecins ayant une solide expérience dans votre traitement spécifique.
Lisez les avis des patients
Consultez les avis patients réels sur Bookimed pour découvrir leur expérience.
Assurer la communication efficace
Choisissez des cliniques offrant un support linguistique pour un traitement fluide.
Demander les services
Vérifiez si le prix comprend des services tels que l’hébergement, les transferts locaux et le suivi afin d’éviter les coûts cachés.

Bookimed Insights : Meilleurs spécialistes de polykystose rénale en Chine (2026)

Bookimed a coordonné 53673 demandes pour le traitement de Polykystose rénale en Chine, en collaboration avec 1 spécialistes. Les médecins de ce tableau se distinguent régulièrement par leurs qualifications et leur expertise à répondre aux besoins spécifiques des patients. Toutes les informations proviennent de cas réels de patients et d'offres de traitement créées par nos cliniques partenaires.
ClassementMédecinexpérienceBon choix pourCe qui les distingueClinique et emplacementConsultation
#142 années d'expérienceMaladie rénale chroniqueExpert de premier plan en médecine traditionnelle chinoise, spécialisé dans les pathologies rénales. Chercheur primé et auteur de plusieurs ouvrages cliniques.
Chine
Prix sur demande

FAQ

Ces FAQ sont basées sur les questions de patients réels cherchant des soins médicaux avec Bookimed. Les réponses sont fournies par des experts médicaux et des représentants de cliniques réputées.

How does Chinese treatment for PKD differ from conventional Western medicine?

Chinese treatment for polycystic kidney disease focuses on systemic balance and potential cyst reduction. Western protocols primarily use blood pressure control and Tolvaptan to manage symptoms. Chinese medicine employs herbal applications and osmotherapy to increase cyst wall permeability. This aiming to reabsorb fluid naturally.

  • Core objective: Western medicine manages complications while Chinese therapy targets internal organ balance.
  • Treatment focus: China utilizes herbal decoctions to resolve blood stasis and tonify vital energy.
  • Intervention types: Western care includes dialysis and transplant. China offers acupuncture and medicated baths.
  • Medication standards: Western centers prescribe ACE inhibitors. Chinese specialists use customized formulas like Astragalus.

Bookimed Expert Insight: Yanda International Hospital in Beijing integrates Western protocols with Traditional Chinese Medicine. This approach is unique because it combines JCI-accredited safety standards with traditional techniques. Patients often seek these hybrid models when standard Western medications like Tolvaptan cause excessive thirst or fatigue. Leading experts like Dr. Wang He Tian specialize in treating circulatory disorders alongside kidney disease. This suggests that Chinese therapy aims to improve renal hemodynamics rather than just targeting cyst growth.

Patient Consensus: Patients note that Chinese protocols often include dietary changes and less invasive methods. Some report stabilized kidney function but emphasize the need for regular Western scans to verify long-term results.

Is Tolvaptan available and safe for international PKD patients in China?

Tolvaptan is available in China but primarily prescribed off-label for polycystic kidney disease (PKD). While used for heart failure, official approval for ADPKD is limited. International patients can access it at major centers. Safety is generally high with strict liver monitoring protocols.

  • Regulatory status: Regulators have not officially approved tolvaptan for ADPKD in mainland China.
  • Access points: Top-tier academic hospitals in Beijing and Shanghai often provide off-label prescriptions.
  • Patient safety: Studies show Chinese patients tolerate lower doses than those used in Western countries.
  • Liver monitoring: Mandatory liver function tests are required every two weeks to prevent toxicity.

Bookimed Expert Insight: Yanda International Hospital serves over 2,500,000 patients yearly with JCI-accredited safety standards. Expert physicians like Dr. Wang He Tian specialize in complex kidney cases. They often combine international medication protocols with traditional Chinese medicine for holistic management. This integrated approach can help mitigate common tolvaptan side effects like thirst or frequent urination.

Patient Consensus: Patients note it is essential to have genetic confirmation of ADPKD before seeking tolvaptan to avoid unnecessary side effects. Many emphasize that while the drug is accessible in major cities, travel insurance or a significant budget is needed for the monthly costs.

Which hospitals in China are reputable for integrated PKD care and accept foreign patients?

Yanda International Hospital and Shijiazhuang Hospital of Nephropathy are reputable Chinese centers for integrated Polycystic Kidney Disease (PKD) care. These facilities hold JCI accreditation. They combine modern Western nephrology with Traditional Chinese Medicine (TCM). Specialized programs focus on managing cyst growth and improving renal function.

  • Hospital classification: Yanda is a Class A Level III facility.
  • Integrated protocols: Centers use Micro-Chinese Medicine Osmotherapy and acupuncture.
  • Specialized expertise: Dr. Wang He Tian manages complex PKD cases.
  • Patient capacity: Yanda International Hospital treats 2,500,000 patients annually.

Bookimed Expert Insight: While many choose Beijing for reputation, Yanda International Hospital stands out for scale. It operates 3,000 beds and 39 departments. This infrastructure supports complex PKD cases requiring multidisciplinary care. Dr. Wang He Tian specifically integrates andrology and urology. This is vital for male PKD patients facing reproductive complications.

Patient Consensus: Patients note that top-tier hospitals like those in Shanghai often require private interpreters. Many suggest using hospital apps for teleconsultations before traveling to confirm insurance coverage.

What lifestyle directives do Chinese clinics give PKD patients to protect kidney function?

Chinese clinics treat polycystic kidney disease by combining standard nephrology with traditional practices to slow cyst growth. Directives emphasize strict salt reduction, blood pressure control under 120/80 mmHg, and Avoiding high-impact activities. Experts at JCI-accredited facilities like Yanda International Hospital integrate these lifestyle changes with specialized medical protocols.

  • Sodium restriction: Limits intake to under 2 grams daily to prevent hypertension and cyst expansion.
  • Activity limits: Recommends gentle movements like Tai Chi while strictly banning high-contact sports.
  • Dietary balance: Encourages black beans and seaweed while limiting spicy or internal heat foods.
  • Hydration protocol: Advises 2-3 liters of water daily to suppress hormones that stimulate growth.

Bookimed Expert Insight: Yanda International Hospital combines international protocols with traditional approaches, serving over 2,500,000 patients annually. Data suggests that high-volume Class A Level III clinics provide superior outcomes by integrating specialists like Dr. Wang He Tian. He is a leading expert in both traditional medicine and complex urological cases.

Patient Consensus: Patients note it is vital to avoid common pain relievers like ibuprofen which may harm kidneys. Many find that switching to low-impact walking helps manage blood pressure without risking cyst rupture.

Are there new experimental drugs from Chinese research that may slow cyst formation?

Chinese research into polycystic kidney disease focuses on natural compounds like Emodin and Triptolide to inhibit cyst expansion. These experimental drugs target signaling pathways including Wnt/beta-catenin and mTOR to reduce cell proliferation. Most research remains in preclinical stages using animal models to demonstrate efficacy.

  • Emodin therapy: This rhubarb-derived compound inhibits the Wnt/beta-catenin pathway to slow kidney cyst growth.
  • Synergistic combinations: Ginkgolide B and Curcumin together may inhibit up to 90% of cyst formation.
  • Nanoparticle research: Melanin-like nanoparticles reduce oxidative stress to dose-dependently inhibit cystic growth in models.
  • Expert centers: JCI-accredited facilities like Yanda International Hospital integrate traditional approaches with modern protocols.

Bookimed Expert Insight: While many Chinese clinics highlight individual natural compounds, the strongest clinical potential lies in Class A Level III institutions. Yanda International Hospital serves 2,500,000 patients yearly and combines these experimental traditional methods with international standards. Prof. Dr. Wang He Tian at this facility specializes in complex kidney cases and has authored 10 books on integrated medicine. This volume of patients and academic leadership suggests a more structured environment for accessing evolving therapies than smaller, unaccredited centers.

Patient Consensus: Patients emphasize tracking cyst growth through serial MRIs and advise caution regarding unverified herbal reducers found in private groups. Many note that while some see slowed growth, others report a drop in kidney function indicators like eGFR.

How is patient monitoring and follow-up organized after returning home?

Patients manage polycystic kidney disease follow-up through structured discharge plans and remote monitoring. Chinese hospitals provide detailed summaries for medication and symptom tracking. Scheduled video consultations and local lab tests verify kidney function. This dual-layer approach ensures continuous care after leaving the facility.

  • Discharge summary: Instructions cover medication changes, diet, and emergency red-flag symptoms.
  • Remote monitoring: Specialists use video calls to adjust care based on local results.
  • Local diagnostics: Patients perform blood work and ultrasounds at home every 14 days.
  • Vital tracking: Daily logs for blood pressure and weight help prevent fluid retention.

Bookimed Expert Insight: JCI-accredited facilities like Yanda International Hospital manage massive volumes of 2,500,000 patients yearly. This scale allows their 39 departments to create highly standardized digital tracking protocols. Large academic centers in Beijing often use these internal data systems to coordinate with international patients. This structure helps bridge the gap between Chinese traditional medicine and modern nephrology.

Patient Consensus: Patients often use apps to log daily urine output and swelling symptoms for their doctors. Having a dedicated family member help with these daily logs makes the remote transition much smoother.

What are common eligibility requirements for the integrative PKD programs?

Integrative PKD programs in China require a confirmed Autosomal Dominant Polycystic Kidney Disease diagnosis and specific renal function levels. Patients typically need an eGFR above 30 mL/min/1.73 m2 to qualify. Facilities like Yanda International Hospital in Beijing accept only adult patients for these combined traditional and international protocols.

  • Renal function: Patients generally need an eGFR between 30 and 60 mL/min/1.73 m2.
  • Cyst criteria: Imaging must show more than 15 cysts to meet operable status.
  • Kidney volume: Total volume per kidney should ideally remain under 2,000 mL.
  • Health stability: Active infections or blood pressure over 160/100 typically disqualify participants.

Bookimed Expert Insight: While many programs focus solely on Western medicine, Class A level III clinics like Yanda International Hospital offer a distinct advantage. They integrate traditional Chinese approaches with international protocols for 2,500,000 patients annually. This high volume suggests that eligibility may also depend on a patient's readiness for long-term lifestyle and dietary shifts.

Patient Consensus: Patients emphasize getting a detailed kidney volume ultrasound before traveling to avoid remote rejection. They note it is vital to stabilize blood pressure and clear any urinary tract infections first.